Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients

Front Immunol. 2024 Jan 10:14:1349296. doi: 10.3389/fimmu.2023.1349296. eCollection 2023.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1188818.].

Keywords: CAR T-cell therapy; NGS (Next-Generation Sequencing); PET/CT 18F-FDG; ctDNA (circulating tumor DNA); follicular lymphoma; minimal residual disease; monitoring.

Publication types

  • Published Erratum